RB
OSIR

Rodgers Brothers’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Rodgers Brothers’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-10,600
Closed -$196K – 172
2015
Q3 		$196K Buy
+10,600
New +$205K 0.1% 152
2015
Q2 		– Sell
-12,100
Closed -$213K – 164
2015
Q1 		$213K Buy
12,100
+1,700
+16% +$28.6K 0.1% 150
2014
Q4 		$166K Hold
10,400
– – 0.08% 149
2014
Q3 		$131K Sell
10,400
-1,500
-13% -$21.4K 0.07% 143
2014
Q2 		$186K Buy
11,900
+1,900
+19% +$27.9K 0.09% 144
2014
Q1 		$131K Buy
+10,000
New +$156K 0.06% 165

Other funds holding OSIR

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QI
QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return

Rodgers Brothers's OSIR Position: Q4 2015 in Review

Rodgers Brothers sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q4 2015, closing a stake of 10,600 shares — an estimated $196K sold.

Rodgers Brothers first reported a position in OSIR in Q1 2014 and held it in 6 quarters. The position peaked at $213K in Q1 2015. 81 funds tracked by Wall St. Rank hold OSIR as of Q4 2015.

  • Rodgers Brothers reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Rodgers Brothers sold 10,600 Osiris Therapeutics, Inc. Common Stock shares in Q4 2015, an estimated $196K.
  • Rodgers Brothers first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2014 and held it in 6 quarters.
  • Rodgers Brothers's Osiris Therapeutics, Inc. Common Stock position peaked at $213K in Q1 2015.
  • 81 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q4 2015.

Based on Rodgers Brothers's 13F filing for Q4 2015, filed 16 Feb 2016.